# Secretome Therapeutics, Inc. — Form D

Secretome Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-02. The offering totals $10.9M, of which $6.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-02-02
- Form: D
- Accession: 0001961833-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.9M
- Amount sold: $6.9M
- Remaining: $4.0M
- Minimum investment: $1
- Investors: 48
- Date of first sale: 2022-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-472444

## Issuer

- Name: Secretome Therapeutics, Inc.
- CIK: 0001961833
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 3060 PEGASUS PARK DR, DALLAS, TX, 75247
- Phone: 646.526.9628

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| VINEET JINDAL | Director | DALLAS, TX |
| SUNJAY KAUSHAL | Director | DALLAS, TX |
| William Niland | Director | Baltimore, MD |
| HENRIK RASMUSSEN | Director | DALLAS, TX |
| ANGELA SHEN | Director | DALLAS, TX |
| VINEET JINDAL | Executive Officer | DALLAS, TX |

## More

- [CIK 1961833 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1961833&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001961833-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.